New immune cell therapy tested for tough childhood cancer
Disease control
Recruiting now
This early-stage trial is testing a new treatment for children and young adults whose high-risk neuroblastoma has come back or hasn't responded to standard treatments. Doctors will collect a patient's own immune cells, modify them in a lab to better target the cancer, and then in…
Phase: PHASE1, PHASE2 • Sponsor: Roberto Chiarle • Aim: Disease control
Last updated Mar 09, 2026 14:27 UTC